What are the types of eye lesions?

11 September 2017
Comments: 0
11 September 2017, Comments: 0

Eye lesions steadily increase in size but might require years before growing into a noticeable size. Most of these lesions trigger surface irritation which results to continuous redness and discomfort.

Individuals who have these symptoms must have the lesion assessed by a doctor so that the right treatment is started.



Pinguecula are small-sized lesions that generally have a yellowish tint and grow on the white part of the eye.

Pinguecula are small-sized lesions that generally have a yellowish tint and grow on the white part of the eye. These elevated bumps do not possess any cancerous potentials and does not disrupt vision.

Exposure to the sun might heighten the risk for acquiring this form of lesion. These eye lesions can trigger surface irritation especially as the size of the growth increases. Over-the-counter variants of artificial tears can provide comfort. In most cases, the lesions do not necessitate treatment or removal with surgery unless they trigger significant discomfort or the size disrupts with eyelid functioning.


A pterygium grows on the white part of the eye and steadily spreads into the cornea. These eye lesions often have a triangular shape with a fleshy appearance. There is an increased risk for pterygium with sun exposure.

This can trigger irritation and redness. Artificial tears can help with the minor symptoms. Prolonged growth can eventually disrupt vision. In such instances, the surgeon might suggest removal of the lesion but there is likelihood for the growth to recur.

Conjunctival nevus

These eye lesions might develop on the white part of the eye or conjunctiva. This might have a darkened pigmented color or appear clear and slightly elevated. In most cases, the nevus grows to a certain size and stops growing.

If the nevus continues to develop, the doctor will conduct a biopsy to pinpoint if it has cancerous potential. Most of the nevi are considered benign in nature but some are malignant.

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha * Time limit is exhausted. Please reload CAPTCHA.